General Information
Revision date
2006-07-06
Product name
KLORSEPT
Manufacturer Name
Medentech Limited
Icons in SDS
Company Information
company name
Medentech Limited
Section 2
SECTION 2: Hazards identification
Product No. (% w/w) Troclosene Sodium / 1,3,5 - Triazine 50% 613-030-00-X 220-767-7 O; Xn; N - 2,4,6 (1H, 3H, 5H) - trione, 1, 3 - R8, R22, R31, dichloro-, sodium salt R36/37, R50/53 CAS No. 2893 - 78 - 9 Adipic Acid 22% 607-144-0-9 201-132-3 XI , R36, CAS No. 000124-04-9 Important Note: the classification descriptions given in this section relate to the components in their pure form and do not correspond to the classification of this preparation (see section 16 for full description of R phrases) The classification of Klorsept as supplied is given in Section 15. Hazards Identification. Most Important Hazards: Classification according to the European Directive on Classification of Hazardous Preparations 1999/45/EC (Conventional Method) Contact with combustible materials may cause fire Contact with acids liberates toxic gases Irritating to eyes and respiratory system Very toxic to aquatic organisms, may cause long term effects in the environment. SHORT TERM EXPOSURE (ACUTE) INHALATION: Breathing dust or fumes is expected to be a primary route of exposure and may cause throat and respiratory tract irritation. EYES: Irritating to Eyes. Direct eye contact with the product may cause stinging, excess tearing and redness. SKIN: Not considered irritating to skin. Repeated skin contact may cause dermatitis and itching. Symptoms are generally alleviated when exposure ends. INGESTION: Ingestion of the product will irritate the mouth, oesophagus and other tissues of the digestive system. Symptoms of such over exposure may include vomiting, diarrhoea and nausea REPEATED EXPOSURE (CHRONIC) No known chronic effects Chronic exposure to large amounts of this preparation has not yet been characterised and the irritating properties of the compound make such an exposure highly unlikely.